Progressive gait ataxia and intention tremor in a case of Bing-Neel syndrome.
Stephan
S
Kolbaske
Annette
A
Grossmann
Reiner
R
Benecke
Matthias
M
Wittstock
D001812:Blood-Brain Barrier / Q000473:pathology / Q000503:physiopathology; D001921:Brain / Q000473:pathology* / Q000503:physiopathology; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000627:therapeutic use; D020234:Gait Ataxia / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007964:Leukocytosis / Q000150:complications* / Q000503:physiopathology; D008213:Lymphocyte Activation / Q000276:immunology; D008214:Lymphocytes / Q000378:metabolism / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010950:Plasma Cells / Q000378:metabolism / Q000473:pathology; D011149:Pons / Q000473:pathology / Q000503:physiopathology; D013577:Syndrome; D016896:Treatment Outcome; D014202:Tremor / Q000209:etiology* / Q000503:physiopathology; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000503:physiopathology
D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D004248:DNA (Cytosine-5-)-Methyltransferases